Earnings History Data for Oramed Pharmaceuticals (ORMP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Oramed Pharmaceuticals
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-03-2024 | AH | ORMP | Oramed Pharmaceuticals | 131.00 | -0.08 | -0.12 | 0.00 | 2.87 | 0.0 (0.00%) |
2.82 | -0.05 (-1.75%) |
1.67 - 5.25 | 137,285 | 250,000 | 7,479 | |||
|
|
||||||||||||||||||
| 10-11-2022 | AH | ORMP | Oramed Pharmaceuticals | 257.00 | -0.72 | -0.26 | 0.00 | Oramed Pharmaceuticals GAAP EPS of -$0.18, revenue of $2.02M [11/10/2022 5:04 PM] |
7.52 | 0.94 (14.29%) |
6.58 | 0.0 (0.00%) |
3.59 - 29.24 | 499,278 | 210,000 | 202 | ||
|
||||||||||||||||||
| 14-01-2021 | AH | ORMP | Oramed Pharmaceuticals Inc. | 102.99 | -0.23 | -0.16 | -0.15 | Oramed Pharmaceuticals EPS beats by $0.42, revenue in-line [1/14/2021 4:34 PM] |
4.34 | -0.12 (-2.69%) |
4.75 | 0.29 (6.50%) |
2.40 - 5.71 | 237,904 | 175,150 | 3,529 | ||
| 07-07-2020 | ?? | ORMP | Oramed Pharmaceuticals Inc. | 81.94 | -0.10 | -0.15 | -0.23 | Oramed Pharmaceuticals EPS beats by $0.10, beats on revenue [7/8/2020 3:07 PM] |
3.35 | -0.02 (-0.74%) |
0.0 | 0.0 (0.00%) |
2.32 - 6.05 | 101,468 | 90,122 | 0 | ||
|
|
||||||||||||||||||